Positive Feedback And Tumorigenesis
Monday, January 2, 2012
Cancer cells are basically immortal. The acquisition of an infinite capability to divide - the method of immortalization - may be a central event within the genesis of tumors. Normally, cells are subject to stringent mechanisms that management their proliferation. along these make sure that pre-malignant cells are induced to enter a senescent, non-dividing state or to endure apoptosis, i.e. commit suicide. a hunt team led by Professor Heiko Hermeking and Dr. Antje Menssen from LMU's Institute of Pathology has currently discovered how the regulatory protein c-MYC subverts these controls, therefore facilitating the expansion of tumors. High levels of c-MYC, that are gift in most tumor cells, activate SIRT1, an enzyme that inhibits each senescence and apoptosis. The new results show that the 2 proteins really kind a positive feedback loop, in that SIRT1 conjointly promotes the activity of c-MYC. traditional cells avoid this vicious circle as a result of they keep the gene that codes for c-MYC turned off, unless they receive growth-promoting signals. In tumor cells, this mechanism not functions and therefore the cells will proliferate unchecked. Their latest findings have implications for cancer treatment, as Menssen explains: "Our results indicate that tumor sorts during which c-MYC plays an important role, like lymphomas and colon or breast cancers, ought to be particularly at risk of pharmacological inhibitors that interrupt the feedback loop. especially, mixtures of medication that interact with totally different parts of the loop may give a brand new route to effective therapies of those malignancies." (PNAS 19.-23.12)
The c-MYC protein is concerned within the management of the many basic biological functions, as well as cell growth and division. it's thus important for processes that need cell proliferation, like embryonic development and therefore the generation of all the cell sorts within the blood. Overproduction of c-MYC, on the opposite hand, will have lethal consequences for the organism. Continuous synthesis of c-MYC may be a distinguished feature of immortalized cells, that divide in an uncontrolled fashion and therefore facilitate the formation of tumors. Normally, multiple mechanisms serve to control the expression of the gene for c-MYC, and keep the extent of the protein gift in cells at intervals applicable limits. In essence, the gene is activated solely when a cell is instructed to try to to thus by specific growth-promoting signals. If this failsafe mechanism is disabled, a second internal system switches in. This back-up circuit ensures that increased concentrations of c-MYC cause premature cell senescence (which makes cells unresponsive to growth signals) and induce programmed cell death. However, in tumor cells, these safeguards not operate - and in some tumors and cell sorts it's emerged that c-MYC itself is chargeable for knocking them out. "How c-MYC achieves this has remained largely unclear," says Hermeking. so as to clarify the mechanisms concerned, the researchers centered on the enzyme SIRT1 as a doable accomplice of c-MYC. As Hermeking explains, "SIRT1 gave the impression to us a probable candidate as a result of a connected enzyme has been shown to play a job in extending the lifespan of cells in lower organisms. In human cells, SIRT1 is thought to inhibit a regulator that promotes senescence and programmed cell death."
The hunch turned out to be correct, since the team, including molecular biologists from Aachen University and therefore the Karolinska Institute in Stockholm, was ready to show that c-MYC really enhances SIRT1 operate in a very range of various ways that. First, it activates NAMPT (nicotinamide phosphoribosyltransferase), that is chargeable for the synthesis of a molecule needed for the action of SIRT1. Secondly, c-MYC represses an inhibitor of SIRT1, thus releasing an additional brake on its operate. Finally, SIRT1 itself potentiates these effects by reducing the speed of degradation of c-MYC. the tip result's a positive feedback loop that drives the continual accumulation of each SIRT1 and c-MYC within the cell.
The c-MYC protein is synthesized in massive amounts in most tumors. Furthermore, in sure cancers, like lymphomas and cancers of the colon and therefore the breast, c-MYC is thought to play a causative role within the origin of the first tumor. In these cases, mutations within the c-MYC gene itself, or in genes that regulate its expression, lead to constant production of the c-MYC protein. The new findings are therefore of specific relevance for the event of latest treatment choices for these styles of cancer, since one would expect them to be highly sensitive to direct inhibition of SIRT1 or NAMPT. apparently, many studies in recent years have revealed that levels of NAMPT also are increased in several tumors. Indeed, a chemical inhibitor of NAMPT is already undergoing clinical trials. "Our study strongly suggests that the feedback loop initiated by excess c-MYC drives the overproduction of NAMPT. a mix of medication may|that may|that will} permit us to inhibit the actions of each SIRT1 and NAMPT might thus have a synergistic result and will open up new therapeutic prospects," Menssen points out.
In addition, the new findings raise queries concerning the allegedly positive result of a daily glass of red wine on lifespan. The putative health advantages of this regime are attributed partially to the activation of SIRT1 by the compound resveratrol, that is found in red wine. Indeed, business development of pharmacological SIRT1 activators like resveratrol is already underway - within the hope that they're going to slow the aging method and block the event of obesity and diabetes. during this context, Hermeking advises caution: "In the sunshine of our results, these agents ought to solely be used once additional intensive study."
The project was supported by a Habilitation Fellowship (funded by the Exzellence Initiative at LMU) to Dr. Antje Menssen, and by the Deutsche Krebshilfe e.V. and therefore the Max-Planck-Society. (göd)
The c-MYC protein is concerned within the management of the many basic biological functions, as well as cell growth and division. it's thus important for processes that need cell proliferation, like embryonic development and therefore the generation of all the cell sorts within the blood. Overproduction of c-MYC, on the opposite hand, will have lethal consequences for the organism. Continuous synthesis of c-MYC may be a distinguished feature of immortalized cells, that divide in an uncontrolled fashion and therefore facilitate the formation of tumors. Normally, multiple mechanisms serve to control the expression of the gene for c-MYC, and keep the extent of the protein gift in cells at intervals applicable limits. In essence, the gene is activated solely when a cell is instructed to try to to thus by specific growth-promoting signals. If this failsafe mechanism is disabled, a second internal system switches in. This back-up circuit ensures that increased concentrations of c-MYC cause premature cell senescence (which makes cells unresponsive to growth signals) and induce programmed cell death. However, in tumor cells, these safeguards not operate - and in some tumors and cell sorts it's emerged that c-MYC itself is chargeable for knocking them out. "How c-MYC achieves this has remained largely unclear," says Hermeking. so as to clarify the mechanisms concerned, the researchers centered on the enzyme SIRT1 as a doable accomplice of c-MYC. As Hermeking explains, "SIRT1 gave the impression to us a probable candidate as a result of a connected enzyme has been shown to play a job in extending the lifespan of cells in lower organisms. In human cells, SIRT1 is thought to inhibit a regulator that promotes senescence and programmed cell death."
The hunch turned out to be correct, since the team, including molecular biologists from Aachen University and therefore the Karolinska Institute in Stockholm, was ready to show that c-MYC really enhances SIRT1 operate in a very range of various ways that. First, it activates NAMPT (nicotinamide phosphoribosyltransferase), that is chargeable for the synthesis of a molecule needed for the action of SIRT1. Secondly, c-MYC represses an inhibitor of SIRT1, thus releasing an additional brake on its operate. Finally, SIRT1 itself potentiates these effects by reducing the speed of degradation of c-MYC. the tip result's a positive feedback loop that drives the continual accumulation of each SIRT1 and c-MYC within the cell.
The c-MYC protein is synthesized in massive amounts in most tumors. Furthermore, in sure cancers, like lymphomas and cancers of the colon and therefore the breast, c-MYC is thought to play a causative role within the origin of the first tumor. In these cases, mutations within the c-MYC gene itself, or in genes that regulate its expression, lead to constant production of the c-MYC protein. The new findings are therefore of specific relevance for the event of latest treatment choices for these styles of cancer, since one would expect them to be highly sensitive to direct inhibition of SIRT1 or NAMPT. apparently, many studies in recent years have revealed that levels of NAMPT also are increased in several tumors. Indeed, a chemical inhibitor of NAMPT is already undergoing clinical trials. "Our study strongly suggests that the feedback loop initiated by excess c-MYC drives the overproduction of NAMPT. a mix of medication may|that may|that will} permit us to inhibit the actions of each SIRT1 and NAMPT might thus have a synergistic result and will open up new therapeutic prospects," Menssen points out.
In addition, the new findings raise queries concerning the allegedly positive result of a daily glass of red wine on lifespan. The putative health advantages of this regime are attributed partially to the activation of SIRT1 by the compound resveratrol, that is found in red wine. Indeed, business development of pharmacological SIRT1 activators like resveratrol is already underway - within the hope that they're going to slow the aging method and block the event of obesity and diabetes. during this context, Hermeking advises caution: "In the sunshine of our results, these agents ought to solely be used once additional intensive study."
The project was supported by a Habilitation Fellowship (funded by the Exzellence Initiative at LMU) to Dr. Antje Menssen, and by the Deutsche Krebshilfe e.V. and therefore the Max-Planck-Society. (göd)
0 comments:
Post a Comment